Smith & Nephew, Mölnlycke Health Care AB and ConvaTec Group PLC are Dominating the Cesko Negative Pressure Wound Therapy Market in 2020

Cesko Negative Pressure Wound Therapy Market is expected to grow with the CAGR of 3.2% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/cesko-negative-pressure-wound-therapy-market

Cesko negative pressure wound therapy market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in negative pressure wound therapy market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.

For instance,

  • In November 2017, Carilex Medical announced the launch of the product for negative pressure wound management called the VT One. The product provides would healing of the wounds while the patients go about their daily life routines. This innovative device has helped in the growth of the market in recent years.

Smith & Nephew is dominating player in negative pressure wound therapy market. The other key players in the market are HARTMANN - RICO spol. s r.o. (a subsidiary of PAUL HARTMANN AG), Talley Group Ltd, Haromed bv, ConvaTec Group PLC, Mölnlycke Health Care AB, Lohmann & Rauscher GmbH & Co. KG, Medela AG and Carilex Medical.

Cesko Negative Pressure Wound Therapy Market

Smith & Nephew

Smith & Nephew has headquartered in Hertfordshire, U.K was founded in 1856. The company engages in the development, manufacture, marketing and sale of medical devices. The company offers Wound Care Products, Wound Therapy Areas, Dressing Types, Orthopaedic Reconstruction, Real Intelligence, Sports Medicine, Trauma & Extremities, and ENT. For instance,

  • In January 2021, Smith & Nephew announced that their product known as PICO has shown positive results in a study. The company stated that the product has helped in reducing surgical site infections along with odds of seroma and those of dehiscence. The study published will help gain credibility among its users and therefore will help in the growth of the market in coming years.          

The company has presence in North America, South America, Europe, Asia-Pacific, and Middle East & Africa. The company has various subsidiaries that are Smith & Nephew Argentina S.R.L.2 (Argentina), Smith & Nephew Pty Limited (Australia), Smith & Nephew Medical (Shanghai) Limited (China), Smith & Nephew S.A. de C.V. (Mexico), Smith & Nephew Limited1 (New Zealand) among others

Mölnlycke Health Care AB

Mölnlycke Health Care AB headquartered in Warsaw, Poland and was founded in year 1849. The company is a world-leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes. The company offers Biogel Surgical Gloves, Hibiclens, Barrier Surgical Staff Clothing, Advanced Wound Care Dressings, Mölnlycke Positioners, Treatment Mepilex Border Ag, NPWT.

For instance,

  • In July 2018, Mölnlycke Health Care AB acquired SastoMed GmbH which is a Germany based wound care products company. This has helped the company increase its product portfolio and helped the healthcare practitioners as well as the patients in faster healing of wounds. This has helped in the growth of the market in recent years.

The company has wide global presence across the world as North America, Europe, Asia-Pacific, South America, Middle East and Africa.

ConvaTec Group PLC

ConvaTec Group PLC is headquartered in Berkshire, U.K. and was founded in 1978. The company is a global medical products and technologies company focused on therapies for the management of chronic conditions with leading market positions in advanced wound care, ostomy care, continence and critical care and infusion devices. The company offers A Stoma, Wound Healing and Skin Protection, Hospital Care.

  • In October 2018, ConvaTec Group PLC announced that its product, Avelle Negative Pressure Wound Therapy (“NPWT”) system received 510(k) clearance Food and Drug Administration (FDA). The FDA clearance provided the product with the recognition among its end users and has helped in the growth of the market in recent years.

The company has wide global presence across North America, South America, Europe, Asia-Pacific, Middle East & Africa. The company has various subsidiaries such ConvaTec Česká republika s.r.o. (Czech Republic), ConvaTec India Pvt Ltd (India), ConvaTec Malaysia Sdn. Bhd. (Malaysia), Convatec Perú SAC (Peru), Kvtech Portugal – Produtos Médicos Unipessoal, Lda. (Portugal) among others.